"/> Invitrogen™ Peptide synthétique Caspase 13 humain | B-LABO France

Invitrogen™ Peptide synthétique Caspase 13 humain

Réf. : BL-RE-176897Réf. fabricant : 15246299 50 μg
141,00 € HT

Synthetic Peptide

Gene ID (Entrez)
8628
Espèces
Human
Méthode de purification
purified
Nom usuel
Human Caspase 13
Concentration
200 μg/mL
Marque
Invitrogen

Caspase-13 Synthetic Peptide, PEP-0074, from Invitrogen.

Apoptosis is related to many diseases and induced by a family of cell death receptors and their ligands. Cell death is finally caused by members of the caspase family of proteases and caspase activated DNases. A novel member in the caspase family was recently identified and designated ERICE (for Evolutionarily Related Interleukin-1 beta Converting Enzyme) and caspase-13. Caspase-13 belongs to the ICE subfamily of caspases. Overexpression of caspase-13 induces apoptosis. Caspase-13 was activated by caspase-8, which is a key enzyme in death receptor induced apoptosis. Caspase-13 is expressed in a variety of human tissues and cell lines.

Caractéristiques techniques

MarqueInvitrogen
Réf. B-LABOBL-RE-176897
Réf. fabricant15246299
Gene ID (Entrez)8628
EspècesHuman
Méthode de purificationpurified
Nom usuelHuman Caspase 13
Concentration200 μg/mL
Contenu et stockage-20°C
FormatLiquid
FormulePBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
À utiliser avec (application)Blocking Assay, Control
Symbole de gène(s)CASP13
LyophiliséNo
Conservateur0.02% sodium azide
Type de produitPeptide
Quantité50 μg
État réglementaireRUO - research use only
Tampon de stockagePBS
Une question, une configuration particulière ?
Contactez-nous pour un devis.